TSUDOME, Riku et al. Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. Cardiology Research, [S. l.], v. 16, n. 6, p. 489–498, 2025. DOI: 10.14740/cr2109. Disponível em: https://cr.elmerpub.com/index.php/cr/article/view/2109.. Acesso em: 21 dec. 2025.